South Korea pulls 1,000 asbestos tainted drugs from shelves
South Korean drug regulators have ordered the recall of 1,222 medical products and pharmaceuticals that may contain asbestos-tainted talcum powder.
Archives for April 8, 2009
New PhRMA chief says healthcare system is ‘broken’
The new chairman of US trade body the Pharmaceutical Research and Manufacturers of America (PhRMA) – AstraZeneca CEO David Brennan – has laid out his vision for reforming the “broken” healthcare system.
Pfizer unveils post-Wyeth takeover R&D structure
Pfizer has outlined its post-Wyeth takeover operating structure, which it believes will ensure the mega-merger boosts R&D and create the “world's premier biopharmaceutical” company.
POM formulation offers pH-responsive targeted colon delivery
Researchers have developed a pH-responsive formulation that could be used to deliver a polyoxometalate (POM), which have broad spectrum anticancer and antiviral properties, to the colon.
CROs pursue international expansion
The past few days have seen a string of announcements from contract research organisations (CROs) which indicate that their appetite for international expansion and development remains unsated.
SAFC service aims to improve CHO media screening
SAFC Biosciences has launched a service for clients undertaking CHO media screening optimisation projects, speeding up an aspect of the development process.
Raptiva finally pulled in US over PML link
Genentech has withdrawn its psoriasis drug Raptiva (efalizumab) from US shelves on continuing concerns about its link to the brain disease progressive multifocal leukoencephalopathy (PML).